Rankings
▼
Calendar
EOLS Q4 2024 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena
EOLS
Evolus, Inc.
$353M
Q4 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$79M
+29.4% YoY
Gross Profit
$50M
63.8% margin
Operating Income
-$2M
-2.9% margin
Net Income
-$7M
-8.6% margin
EPS (Diluted)
$-0.11
QoQ Revenue Growth
+29.2%
Cash Flow
Operating Cash Flow
$5M
Free Cash Flow
$3M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$233M
Total Liabilities
$227M
Stockholders' Equity
$6M
Cash & Equivalents
$87M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$79M
$61M
+29.4%
Gross Profit
$50M
$39M
+29.8%
Operating Income
-$2M
-$9M
+73.2%
Net Income
-$7M
-$12M
+42.6%
Revenue Segments
Product
$79M
100%
← FY 2024
All Quarters
Q1 2025 →